Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD”

3,724 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,724 results

Not applicableActive Not RecruitingNCT05636592
What this trial is testing

Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 250
Not applicableStudy completedNCT06829992
What this trial is testing

Effects of Applying Kinesio Tapping on Primary Dysmenorrhea in Football Players

Who this might be right for
Primary Dysmenorrhea (PD)
Federal University of São Paulo 50
Testing effectiveness (Phase 2)UnknownNCT05055167
What this trial is testing

Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IV
The First Affiliated Hospital of Xiamen University 20
Not applicableLooking for participantsNCT07635771
What this trial is testing

Development of a Multidimensional Predictive Model of Dystocic Labor. Association of Physical Condition and Psychosocial Factors With the Birth Process and Breastfeeding Success.

Who this might be right for
Labor and ChildbirthLabor (Obstetrics)--ComplicationsHand Strength+4 more
Institut Investigacio Sanitaria Pere Virgili 420
Testing effectiveness (Phase 2)UnknownNCT05267392
What this trial is testing

Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or Chemoradiotherapy

Who this might be right for
Non-small Cell Lung Cancer
Instituto Portugues de Oncologia, Francisco Gentil, Porto 30
Testing effectiveness (Phase 2)Study completedNCT03562871
What this trial is testing

IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC

Who this might be right for
NSCLC
IO Biotech 109
Not applicableStudy completedNCT02898740
What this trial is testing

Telephone-linked Home-based Exercise Training in PD

Who this might be right for
Parkinson's Disease
VA Office of Research and Development 40
Testing effectiveness (Phase 2)Study completedNCT00209508
What this trial is testing

2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD

Who this might be right for
Parkinson's Disease
Eisai Inc. 200
Not applicableUnknownNCT04197674
What this trial is testing

China Q Cohort Study

Who this might be right for
End Stage Renal Disease on DialysisPeritoneal DialysisHemodialysis
Sun Yat-sen University 903
Early research (Phase 1)Study completedNCT00481117
What this trial is testing

Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 37
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Testing effectiveness (Phase 2)Study completedNCT05284617
What this trial is testing

Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Rivus Pharmaceuticals, Inc. 67
Early research (Phase 1)Study completedNCT05011097
What this trial is testing

A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Wuhan YZY Biopharma Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT04177810
What this trial is testing

Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Large-scale testing (Phase 3)Active Not RecruitingNCT05671510
What this trial is testing

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

Who this might be right for
Non Small Cell Lung Cancer
OncoC4, Inc. 630
Early research (Phase 1)Study completedNCT00848510
What this trial is testing

EMD 525797 in Colorectal and Ovarian Cancer Patients With Liver Metastases

Who this might be right for
Colorectal and Ovarian Cancer Patients With Liver Metastases
Merck KGaA, Darmstadt, Germany 41
Testing effectiveness (Phase 2)Study completedNCT02217410
What this trial is testing

CCFZ533X2201 - PoC Study in de Novo Renal Transplantation

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 59
Very early researchStudy completedNCT04414813
What this trial is testing

Stereotactic Transplantation of hAESCs for Parkinson's Disease

Who this might be right for
Parkinson's Disease
Shanghai East Hospital 3
Early research (Phase 1)Study completedNCT01044537
What this trial is testing

A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 50
Not applicableStudy completedNCT04877951
What this trial is testing

PC in Stance and During Functional Mobility Following BIG for PD

Who this might be right for
Parkinson Disease
University of South Dakota 5
Next Page